Trials / Completed
CompletedNCT06978010
Efficacy of Platelet-rich Plasma in Improving Postoperative Scarring After Cesarean Delivery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Saint Andrew Hospital Constanta · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Cesarean section often leads to postoperative scarring, which can impact both physical and psychological well-being. Platelet-rich plasma (PRP), rich in growth factors, is used in regenerative medicine to promote healing and reduce inflammation.
Detailed description
Background: Cesarean section often leads to postoperative scarring, which can impact both physical and psychological well-being. Platelet-rich plasma (PRP), rich in growth factors, is used in regenerative medicine to promote healing and reduce inflammation. Objective: To evaluate the efficacy of intraoperative PRP in accelerating scar healing after cesarean section, using: Six visual scar assessment scales (Manchester, POSAS, Vancouver, VAS, NRS, REEDA) Hematological parameters (hemoglobin, hematocrit, leukocytes, platelets) Methods: Design: Prospective clinical study, 100 patients undergoing cesarean section with intraoperative PRP. Intervention: 10 ml PRP administered intraoperatively (5 ml before hysterography, 5 ml subcutaneously before skin closure). Assessments: Scar evaluation at day 7 and day 40 post-op using six scar scales; hematological parameters measured at both time points. Statistics: Wilcoxon paired samples test and Pearson correlation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Platelet-Rich Plasma (PRP) intraoperatively | Patients receive platelet-rich plasma (PRP) intraoperatively during cesarean section (5 ml before hysterography, 5 ml subcutaneously before skin closure). |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
- First posted
- 2025-05-18
- Last updated
- 2025-05-21
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT06978010. Inclusion in this directory is not an endorsement.